Known targets — ChEMBL curated mechanism
PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Pentetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | EYA2 | O00167 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL28302111 | 0.97 | GSR (0.67) | GSRTSHRTDP1CYP2C19KDM4E | |
| Edetic Acid SCHEMBL30301418 | 0.97 | GSR (0.67) | GSRTSHRTDP1CYP2C19KDM4E | |
| Edetic Acid SCHEMBL4385396 | 0.93 | GSR (0.60) | GSRTSHRTDP1CYP2C19KDM4E | |
| Edetic Acid SCHEMBL4385387 | 0.93 | GSR (0.60) | GSRTSHRTDP1CYP2C19KDM4E | |
| Nitrilotriacetic Acid SCHEMBL4200594 | 0.91 | GSR (0.74) | GSRTSHRCYP2C19BLMARG2 | |
| SCHEMBL5613110 | 0.86 | TDP1 (0.50) | GSRTSHRTDP1CYP2C19KDM4E | |
| SCHEMBL2305699 | 0.86 | GSR (0.53) | GSRTSHRTDP1CYP2C19KDM4E | |
| SCHEMBL158633 | 0.86 | GSR (0.53) | GSRTSHRTDP1CYP2C19KDM4E | |
| SCHEMBL10088294 | 0.84 | GSR (0.52) | GSRTSHRTDP1CYP2C19KDM4E | |
| Water SCHEMBL1336386 | 0.84 | GSR (0.52) | GSRTSHRTDP1CYP2C19KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5707604-A | ENHANCEMENT OF MAGNETIC RESONANCE IMAGES, METAL CHELATE COMPOUND BOUND TO A CARRIER SUCH AS A SULFATED POLYSACCHARIDE | ACCESS PHARMACEUTICALS, INC. (US) | 1998-01-13 | — | — | US | claimed |
| US-5672334-A | FOR ENHANCING MAGNETIC RESONANCE SIGNALS | ACCESS PHARMACEUTICALS, INC. (US) | 1997-09-30 | — | — | US | claimed |
| EP-0731713-A1 | METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS | Access Pharmaceuticals Inc. (US) | 1996-09-18 | — | — | EP | claimed |
| WO-1995014491-A9 | METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS | — | 1995-09-28 | — | — | WO | claimed |
| WO-1995014491-A2 | METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS | ACCESS PHARMACEUTICALS, INC. (US) | 1995-06-01 | — | — | WO | claimed |
| EP-0726781-B1 | IN VIVO AGENTS COMPRISING RADIOACTIVE METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS, GIVING IMPROVED SITE-SELECTIVE LOCALIZATION, UPTAKE MECHANISM, SENSITIVITY AND KINETIC-SPATIAL PROFILES | ACCESS PHARMA INC (US) | 2001-08-22 | — | — | EP | disclosed |
| US-6106866-A | ANTITUMOR AGENTS AND DERMATAN SULFATE | ACCESS PHARMACEUTICALS, INC. (US) | 2000-08-22 | — | — | US | disclosed |
| US-5707604-A | ENHANCEMENT OF MAGNETIC RESONANCE IMAGES, METAL CHELATE COMPOUND BOUND TO A CARRIER SUCH AS A SULFATED POLYSACCHARIDE | ACCESS PHARMACEUTICALS, INC. (US) | 1998-01-13 | — | — | US | disclosed |
| US-5672334-A | FOR ENHANCING MAGNETIC RESONANCE SIGNALS | ACCESS PHARMACEUTICALS, INC. (US) | 1997-09-30 | — | — | US | disclosed |
| EP-0794796-A1 | COMPLEXES OF DERMATAN SULFATE AND DRUGS, GIVING IMPROVED PHARMACOKINETICS | Access Pharmaceuticals, Inc. (US) | 1997-09-17 | — | — | EP | disclosed |
| EP-0731713-A1 | METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS | Access Pharmaceuticals Inc. (US) | 1996-09-18 | — | — | EP | disclosed |
| EP-0726781-A1 | IN VIVO AGENTS COMPRISING RADIOACTIVE METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS, GIVING IMPROVED SITE-SELECTIVE LOCALIZATION, UPTAKE MECHANISM, SENSITIVITY AND KINETIC-SPATIAL PROFILES | Access Pharmaceuticals Inc. (US) | 1996-08-21 | — | — | EP | disclosed |
| WO-1996019242-A1 | COMPLEXES OF DERMATAN SULFATE AND DRUGS, GIVING IMPROVED PHARMACOKINETICS | ACCESS PHARMACEUTICALS, INC. (US) | 1996-06-27 | — | — | WO | disclosed |
| WO-1995014491-A9 | METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS | — | 1995-09-28 | — | — | WO | disclosed |
| WO-1995014492-A2 | IN VIVO AGENTS COMPRISING RADIOACTIVE METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS, GIVING IMPROVED SITE-SELECTIVE LOCALIZATION, UPTAKE MECHANISM, SENSITIVITY AND KINETIC-SPATIAL PROFILES | ACCESS PHARMACEUTICALS, INC. (US) | 1995-06-01 | — | — | WO | disclosed |
| WO-1995014491-A2 | METAL-ION CHELATES WITH ACIDIC SACCHARIDES AND GLYCOSAMINOGLYCANS | ACCESS PHARMACEUTICALS, INC. (US) | 1995-06-01 | — | — | WO | disclosed |
| EP-0233619-B1 | HIGH MOLECULAR COMPOUNDS HAVING AMINO GROUPS, AND THEIR UTILIZATION | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1992-12-30 | — | — | EP | disclosed |
| US-4855353-A | High molecular compounds having amino groups, and their utilization | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1989-08-08 | — | — | US | disclosed |
| EP-0233619-A1 | High molecular compounds having amino groups, and their utilization | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1987-08-26 | — | — | EP | disclosed |